PRKAA2 and cancer: We thus focused on major cancer metabolism effectors enriched in P-tripeptides and found that the multimeric 5’AMP-activated protein kinase (AMPK) shows occurrences of P-tripeptides in each subunit type (Fig. 3F, Appendix Table S9).